Logo Image
Feature|Videos|December 11, 2025

The Future of Pharma Logistics

Key Takeaways

  • Hear why pharmaceutical executives are reporting feelings of constrainment by current supply chain issues.
  • Learn about the concept of “delivery intelligence” and its role in pharmaceutical cold chain logistics.
SHOW MORE

Hear how “delivery intelligence” is transforming the last mile of pharmaceutical logistics from Jay McHarg, CEO of AeroSafe Global.

Sponsored by AeroSafe Global

Jay McHarg, CEO of AeroSafe Global, discusses how pharmaceutical supply chains are evolving to support advanced therapies. McHarg introduces the concept of “delivery intelligence”—a strategy designed to redefine success in the last mile of delivery by viewing it as the beginning of patient care rather than the end of logistics. He notes that pharmaceutical executives are aware of supply chain challenges but are constrained by outdated infrastructure, including reliance on 70-year-old Styrofoam packaging technology and fragmented vendor models that separate packaging, logistics, and operations.

McHarg calls for a coordinated, technology-enabled approach that extends product protection for longer durations, integrates directly with carriers such as FedEx and UPS to enable real-time interventions, and incorporates operational planning to prevent deliveries when facilities are closed. He emphasizes that such an integrated system is essential to reduce the industry’s current 2–3% daily product loss caused by temperature excursions or delayed deliveries.

Want to continue watching this interview? Click here.

Related to this article

View more
Pharmacist medicine drug lab pharmacy check white coat medicine package computer screen barcode scanner quality control safe care | © Wasun - stock.adobe.com 2150839459
Q&A: Inside the NDC-12 Transition
Liberty Dewey of Cardinal Health breaks down the NDC-12 transition timeline, the four work streams driving it and why the biggest risk sits in trading partner handoffs.
Read more
Ameer Ali
Why Your NDC-12 Roadmap Should Start Now
In the final installment of his interview with Pharmaceutical Commerce, Cencora's Ameer Ali outlines how supply chain stakeholders should prepare systems, processes and trading partners for the shift to NDC-12.
Read more